Wordt geladen...
Prolyl oligopeptidase inhibitor suppresses the upregulation of ACSDKP in patients with acute myeloid leukemia
The aim of the current study was to measure the expression of acetyl-N-Ser-Asp-Lys-Pro (ACSDKP) in patients with acute myeloid leukemia (AML) and the effect of prolyl oligopeptidase inhibitor (POPi) on the bone marrow stromal cells of these patients. Serum and bone marrow stromal cell samples were c...
Bewaard in:
| Gepubliceerd in: | Exp Ther Med |
|---|---|
| Hoofdauteurs: | , , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
D.A. Spandidos
2018
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5996663/ https://ncbi.nlm.nih.gov/pubmed/29904422 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/etm.2018.6111 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|